Carbonic Anhydrase Inhibitors and the Management of Cancer
Journal:
Current Topics in Medicinal Chemistry
Volume:
7
Page:
865-878
Author(s):
Silvia Pastorekova, Juraj Kopacek and Jaromir Pastorek
From ONYX-015 to Armed Vaccinia Viruses: The Education and Evolution of Oncolytic Virus Development
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
133-139
Author(s):
Anne Moon Crompton and David H. Kirn
Clinical Trials with Oncolytic Adenovirus in China
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
141-148
Author(s):
Wang Yu and Hu Fang
Anti-Tumor Activity of Non-Nucleosidic Reverse Transcriptase Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
737-747
Author(s):
Matteo Landriscina, Corrado Spadafora, Mauro Cignarelli and Carlo Barone
Cytotoxic and Allergenic Potential of Bioactive Proteins and Peptides
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
897-920
Author(s):
Rainer Hartmann, Jean-Michel Wal, Herve Bernard and Anne-Kathrin Pentzien
CD40L - A Multipotent Molecule for Tumor Therapy
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
7
Page:
23-28
Author(s):
Angelica Loskog and Thomas H. Totterman
Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Journal:
Current Drug Targets
Volume:
8
Page:
217-235
Author(s):
M. A. Morgan, A. Ganser and C. W. M. Reuter
Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies
Journal:
Current Drug Targets
Volume:
8
Page:
257-268
Author(s):
Torsten Kessler, Frauke Fehrmann, Ralf Bieker, Wolfgang E. Berdel and Rolf M. Mesters
Subject Index To Volune 2
Journal:
Current Cancer Therapy Reviews
Volume:
3
Page:
vi-vi
Author(s):
Bentham Science Publishers
T Cell Costimulatory and Inhibitory Receptors as Therapeutic Targets for Inducing Anti-Tumor Immunity
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
55-70
Author(s):
Jeurgen Foell and Becker Hewes